Abstract
The oral bioavailability and anti-leukaemia activity of Tanshinone IIA (TanIIA) were enhanced by using biotinylated-lipid bilayer coated mesoporous silica nanoparticles (Bio-LB-MSNs) as a vehicle. The in vitro release of TanIIA from TanIIA@MSNs was significantly higher than that of the TanIIA powder (p
Author supplied keywords
Cite
CITATION STYLE
Li, Z., Zhang, Y., Zhang, K., Wu, Z., & Feng, N. (2018). Biotinylated-lipid bilayer coated mesoporous silica nanoparticles for improving the bioavailability and anti-leukaemia activity of Tanshinone IIA. Artificial Cells, Nanomedicine and Biotechnology, 46(sup1), 578–587. https://doi.org/10.1080/21691401.2018.1431651
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.